Jane Street’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,459
| Closed | -$8.73K | – | 5648 |
|
|
2024
Q4 | $8.73K | Sell |
1,459
-1,623
| -53% | -$9.71K | ﹤0.01% | 5677 |
|
|
2024
Q3 | $30.1K | Sell |
3,082
-4,733
| -61% | -$46.2K | ﹤0.01% | 5667 |
|
|
2024
Q2 | $160K | Buy |
+7,815
| New | +$160K | ﹤0.01% | 5493 |
|
|
2024
Q1 | – | Sell |
-1,940
| Closed | -$91.6K | – | 5782 |
|
|
2023
Q4 | $91.6K | Sell |
1,940
-6,915
| -78% | -$326K | ﹤0.01% | 5286 |
|
|
2023
Q3 | $358K | Buy |
8,855
+2,544
| +40% | +$103K | ﹤0.01% | 3900 |
|
|
2023
Q2 | $672K | Buy |
6,311
+5,641
| +842% | +$601K | ﹤0.01% | 3464 |
|
|
2023
Q1 | $200K | Buy |
+670
| New | +$200K | ﹤0.01% | 4683 |
|
|
2022
Q4 | – | Sell |
-792
| Closed | -$150K | – | 5545 |
|
|
2022
Q3 | $150K | Buy |
+792
| New | +$150K | ﹤0.01% | 4723 |
|
|
2022
Q2 | – | Sell |
-4,875
| Closed | -$1.63M | – | 5570 |
|
|
2022
Q1 | $1.63M | Buy |
4,875
+3,410
| +233% | +$1.14M | ﹤0.01% | 2365 |
|
|
2021
Q4 | $476K | Buy |
1,465
+830
| +131% | +$270K | ﹤0.01% | 3524 |
|
|
2021
Q3 | $308K | Sell |
635
-371
| -37% | -$180K | ﹤0.01% | 3928 |
|
|
2021
Q2 | $468K | Sell |
1,006
-772
| -43% | -$359K | ﹤0.01% | 3487 |
|
|
2021
Q1 | $1.23M | Buy |
1,778
+48
| +3% | +$33.2K | ﹤0.01% | 2267 |
|
|
2020
Q4 | $1.28M | Sell |
1,730
-2,815
| -62% | -$2.08M | ﹤0.01% | 1872 |
|
|
2020
Q3 | $3.15M | Buy |
4,545
+4,199
| +1,214% | +$2.91M | ﹤0.01% | 860 |
|
|
2020
Q2 | $294K | Sell |
346
-323
| -48% | -$274K | ﹤0.01% | 3071 |
|
|
2020
Q1 | $239K | Buy |
+669
| New | +$239K | ﹤0.01% | 2749 |
|